Blood Reviews
Volume 24, Issue 6 , Pages 221-225 , November 2010

Anaemia of prematurity: Pathophysiology and treatment

References 

  1. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2008 national Vital Statistics Reports. Centers Disease Control Prevent. 2009;57:7
  2. Maier RJ, Sonntag J, Walka MM, et al. Changing practices of red blood cell transfusions in infants with birth weights less than 1000g. J Pediatr. 2000;136:220–224
  3. Sacher RA, Strauss RG, Luban NL, et al. Blood component therapy during the neonatal period: a national survey of red cell transfusion practices, 1985. Transfusion. 1990;30:271–276
  4. Widness JA. Pathophysiology of anemia during the neonatal period, including anemia of prematurity. NeoReviews. 2008;9:31-e5
  5. Lin JC, Strauss RG, Kulhavy JC, et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics. 2000;106:E19
  6. Widness JA, Seward VJ, Kromer IJ, et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr. 1996;129:680–687
  7. Wardrop CA, Holland BM, Veale KE, Jones JG, Gray OP. Nonphysiological anaemia of prematurity. Arch Dis Child. 1978;53:855–860
  8. Strauss RG, Mock DM, Widness JA, Johnson K, Cress G, Schmidt RL. Post-transfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants. Transfusion. 2004;44:871–876
  9. Stockman JA, Graeber JE, Clark DA, McClellan K, Garcia JF, Kavey RE. Anemia of prematurity: determinants of the erythropoietin response. J Pediatr. 1984;105:786–792
  10. Brown MS, Garcia JF, Phibbs RH, Dallman PR. Decreased response of plasma immunoreactive erythropoietin to “available oxygen” in anemia of prematurity. J Pediatr. 1984;105:793–798
  11. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the “anemia of prematurity”. J Pediatr. 1988;112:935–940
  12. Dame C, Fahnenstich H, Freitag P, Hofmann D, Abdul-Nou T, Bartmann P, et al. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood. 1998;92:3218–3225
  13. Snijders RJ, Abbas A, Melby O, Ireland RM, Nicolaides KH. Fetal plasma erythropoietin concentration in severe growth retardation. Am J Obstet Gynecol. 1993;168:615–619
  14. Widness JA, Susa JB, Garcia JF, Singer DB, Sehgal P, Oh W, et al. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. J Clin Invest. 1981;67:637–642
  15. Ohls RK, Li Y, Trautman MS, Christensen RD. Erythropoietin production by macrophages from preterm infants: implications regarding the cause of the anemia in prematurity. Pediatr Res. 1994;35:169–170
  16. Widness JA, Veng-Pedersen P, Peters C, Pereira LM, Schmidt RL, Lowe LS. Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects. J Appl Physiol. 1996;80:140–148
  17. Obladen M, Sachsenweger M, Stahnke M. Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr. 1988;147:399–404
  18. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK. Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics. 2005;115:1299–1306
  19. Madan A, Kumar R, Adams MM, Benitz WE, Geaghan SM, Widness JA. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J of Perinatol. 2005;25:2–25
  20. Strauss RG. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin. Transfus Med Rev. 2001;15:213–223
  21. Ringer SA, Richardson DK, Sacher RA, Keszler M, Churchill WH. Variations in transfusion practice in neonatal intensive care. Pediatrics. 1998;101:194–200
  22. Bednarek FJ, Weisberger S, Richardson DK, Frantz ID, Shah B, Rubin LP, et al. Variations in blood transfusions among newborn intensive care units. J Pediatr. 1998;133:601–607
  23. Ramasethu J, Luban NL. Red blood cell transfusions in the newborn. Semin Neonatol. 1999;4:5–16
  24. dos Santos AMN, Guinsburg R, Procianoy RS, dos SR, Sadeck L, Netto AA, et al. Variability on red blood cell transfusion practices among Brazilian neonatal intensive care units. Transfusion. 2010;50:150–159
  25. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusions in preterm infants. Pediatrics. 2005;115:1685–1691
  26. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149:301–307
  27. Whyte RK, Kirpalani H, Asztalos EV, et al. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009;123:207–213
  28. Strauss RG. Blood component transfusion for infants. In:  Simon TL,  Snyder EL,  Solheim BG,  Stowell CP,  Strauss RG,  Petrides M editor. Rossi's principles of transfusion medicine. 4th ed. Bethesda, MD: AABB & Blackwell Publishing Ltd; 2009;p. 470–481
  29. Roseff SD, Eder A, Punzalan R, Sloan S, Strauss R, Wong ECC, et al. Pediatric transfusion: a physician's handbook. In: 3rd ed. Bethesda: AABB Press; 2009;
  30. Strauss RG. How I transfuse red blood cells and platelets to infants (invited commentary). Transfusion. 2008;48:209–217
  31. New HV, Stanworth SJ, Engelfriet CP, et al. International forum: neonatal transfusions. Vox Sang. 2009;96:62–85
  32. Strauss RG. Data-driven blood banking practices for neonatal RBC transfusions. Transfusion. 2000;40:1528–1540
  33. Strauss RG, Burmeister LF, Johnson K, et al. AS-1 red cells for neonatal transfusions — a randomized trial assessing donor exposure and safety. Transfusion. 1996;36:873–878
  34. Vamvakas EC. Meta-analysis of clinical studies of the purported deleterious effects of “old” (versus “fresh”) red blood cells: are we at equipoise?. Transfusion. 2010;50:600–610
  35. Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of recombinant human erythropoietin in reducing blood transfusions in the anemia of prematurity. Transfusion. 2001;41:406–415
  36. Donato H, Vain N, Rendo P, Vivas N, Prudent L, Larguia M, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics. 2000;105:1066–1072
  37. Yeo CL, Choo S, Ho LY. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. J Paediatr Child Health. 2001;37:352–358
  38. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F41–F45
  39. Maier RE, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin b ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000g. J Pediatr. 2002;141:8–15
  40. Avent M, Cory BJ, Galpin J, Ballot DE, Cooper PA, Sherman G, et al. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anemia of prematurity in a developing country. J Trop Pediatr. 2002;48:227–233
  41. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?. Arch Dis Child Fetal Neonatal Ed. 2001;84:F96–F100
  42. Amin AA, Alzahrani DM. Efficacy of erythropoietin in premature infants. Saudi Med J. 2002;23:287–290

PII: S0268-960X(10)00040-8

doi: 10.1016/j.blre.2010.08.001

Blood Reviews
Volume 24, Issue 6 , Pages 221-225 , November 2010

Article Tools